Table 4.
Region | Group | Standardized Beta | Relationship | P-value |
---|---|---|---|---|
Superior Frontal Gyrus (L) | Psychopathic | 0.446 | Positive | 0.004** |
Non-psychopathic | 0.188 | Positive | 0.316 | |
Superior Frontal Gyrus (R) | Psychopathic | 0.334 | Positive | 0.013* |
Non-psychopathic | 0.120 | Positive | 0.425 | |
Middle Frontal Gyrus (R) | Psychopathic | 0.412 | Positive | 0.002** |
Non-psychopathic | 0.077 | Positive | 0.602 | |
Middle Frontal Gyrus (L) | Psychopathic | 0.465 | Positive | 0.005** |
Non-psychopathic | 0.269 | Positive | 0.103 | |
Medial Orbitofrontal Cortex (R) | Psychopathic | 0.186 | Positive | 0.092 |
Non-Psychopathic | 0.136 | Positive | 0.350 | |
Putamen (R) | Psychopathic | 0.342 | Positive | 0.032* |
Non-psychopathic | 0.429 | Positive | 0.030* | |
Caudate (R) | Psychopathic | 0.369 | Positive | 0.040* |
Non-psychopathic | 0.298 | Positive | 0.112 | |
Nucleus Accumbens (L) | Psychopathic | 0.225 | Positive | 0.192 |
Non-psychopathic | 0.172 | Positive | 0.405 | |
Nucleus Accumbens (R) | Psychopathic | 0.228 | Positive | 0.168 |
Non-psychopathic | 0.253 | Positive | 0.229 |
As in the original analyses, these analyses control for age, race, substance use, brain volume and PCL-R factor 1 scores. Bolding indicates significance at the
P < 0.01 or
P < 0.05 level.